| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $57.2M | +4.6% |
| R&D Expense | $20.1M | +38.3% |
| SG&A Expense | $23.5M | -2.0% |
| Operating Income | -$15.5M | -47.4% |
| Pre-tax Income | -$11.8M | -48.7% |
| Income Tax | $1K | +102.3% |
| Net Income | -$12.5M | -38.1% |
| EPS (Basic) | -$0.38 | -40.7% |
| EPS (Diluted) | -$0.38 | -40.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -56.1% |
| Current Assets | $33.6M | -23.5% |
| Total Assets | $70.1M | -19.7% |
| Current Liabilities | $10.8M | -29.2% |
| Total Liabilities | $14.5M | -26.2% |
| Stockholders' Equity | $18.3M | -40.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | -305.0% |
| Investing Cash Flow | -$6.0M | +60.8% |
| Financing Cash Flow | -$2.1M | +66.6% |